Pfizer Japan

Pfizer Japan, founded in 1953, is a significant entity within the global pharmaceutical and healthcare sectors, applying scientific innovation and extensive resources to improve lives. The company focuses on the discovery, development, and manufacture of healthcare products, aiming to set standards for quality, safety, and value. Their operations span across developed and emerging markets, striving to advance wellness, prevention, treatments, and cures for challenging diseases. Pfizer Japan's global portfolio includes a range of medicines, vaccines, and well-recognized consumer health care products. The company's commitment extends to collaborating with healthcare providers, governments, and local communities to expand access to reliable and affordable healthcare worldwide. With a revenue of $978.9M and employing between 1,000-5,000 individuals, Pfizer Japan demonstrates substantial operational scale and market presence. Meet Pfizer Japan's team to learn more about their dedicated professionals driving these initiatives. The company's strategic approach involves continuous research and development, ensuring they remain at the forefront of biopharmaceutical innovation. Their efforts are geared towards addressing unmet medical needs and enhancing patient outcomes through scientific excellence and global reach. Pfizer Japan's presence in Asia Pacific underscores its role in regional health initiatives and market development, contributing to the broader mission of global health improvement.